Sign Up For FREE
Health After 50 Alerts!

We value your privacy and will never rent your email address

Health After 50

Consider Cost When Choosing Diabetic Neuropathy Treatment

Comments (0)

If you have diabetes, there’s a 50 percent chance you also have diabetic neuropathy—permanent nerve damage that often affects the feet and legs, causing numbness, burning, sensitivity to touch and sharp, stabbing pain. You may also have turned to topical or oral medications to help relieve your pain and discomfort.

But when you reach for a pain reliever, how do you know whether another drug might do a similar or better job of relieving pain, perhaps for less cost?

Sorting out medical therapies

Mayo Clinic researchers recently set out to compare the effectiveness of drug therapies to relieve diabetic neuropathy pain. After reviewing 65 studies of nearly 27 drug treatments and 13,000 individuals, they couldn’t designate a clear winner among the drugs, especially for long-term relief, because of insufficient evidence. Reporting last November in Annals of Internal Medicine, the researchers agreed that more long-term, head-to-head drug comparisons are needed. In an accompanying commentary, two University of Michigan experts suggested that, with the limited evidence available, cost may be a deciding factor for doctors when choosing a drug to prescribe for easing neuropathy.

Drugs used to treat diabetic neuropathy fall into several categories:

¦ Antidepressants, including tricyclics and serotonin–norepinephrine reuptake inhibitors (SNRIs)

¦ Antiseizure drugs, or anticonvulsants

¦ Topical capsaicin, an over-the-counter pain reliever (available as Capsin and other brands)

¦ Opioids (dextromethorphan, morphine sulfate, tramadol, oxycodone)

The SNRI duloxetine (Cymbalta), the anticonvulsant pregabalin (Lyrica) and the opioid tapentadol (Nucynta) are the only drugs approved by the Food and Drug Administration to treat diabetic neuropathic pain. But doctors regularly use other drugs “off label” because they’re effective in treating chronic pain conditions, including diabetic neuropathy.

Cost and other considerations

The University of Michigan experts suggest that the most important factors to consider are coexisting medical conditions, side effects and cost. Anticonvulsants may be the best option for people who have both epilepsy and neuropathy, say the experts. Similarly, antidepressants may be a smart choice for neuropathy sufferers who are also depressed. Fortunately, the risk of adverse effects for most people is likely to be low at the doses typically used for neuropathic pain.

Costs vary widely among drugs. According to the commentary, retail cost for pregabalin, at about $190 a month, is close to 10 times that of the least-expensive option. Drugs like amitriptyline (a tricyclic antidepressant) and gabapentin (an anticonvulsant) are significantly less expensive, hovering around $13 to $19 a month. Capsaicin is a low-cost, over-the-counter alternative, at about $14 a month.

The most cost-effective approach, say the experts, is to start with a tricyclic antidepressant, followed by gabapentin, reserving higher-cost options for cases in which less costly treatments have failed. This approach supports the ADA’s recommendations.

 

Posted in Diabetes on October 15, 2015


Medical Disclaimer: This information is not intended to substitute for the advice of a physician. Click here for additional information: Health After 50 Disclaimer


Notify Me

Would you like us to inform you when we post new Diabetes Health Alerts?

Post a Comment

Comments

Health After 50 Alerts registered users may post comments and share experiences here at their own discretion. We regret that questions on individual health concerns to the editors cannot be answered in this space.

The views expressed here do not constitute medical advice, and do not represent the position of Scientific American Health After 50 or Remedy Health Media, LLC, which has no responsibility for any comments posted on this site.


Post a Comment


Already a subscriber?

Login

Forgot your password?

New to Health After 50?

Register to submit your comments.

(example: [email protected])

Log-in:

Forgot Password?

Scientific American White Papers

    2016 Diabetes White Paper

    The Diabetes White Paper teaches you how to manage Type 1 and Type 2 diabetes and avoid complications, such as nerve damage, heart disease, kidney failure, and retinopathy. This comprehensive report explains the basics of how your body metabolizes glucose and reviews the latest medications and tools for monitoring your blood glucose. Includes diagrams, glossary, and recent research.

    Read more or order now


Related Titles:

2016 Vision White Paper


Colin A. McCannel, M.D., F.A.C.S., F.R.C.S.C., is Professor of Clinical Ophthalmology at the Jules Stein Eye Institute, University of California, Los Angeles, and Medical Director of UCLA’s Stein Eye Center–Santa Monica. This comprehensive report is essential reading for anyone affected by a vision disorder, including low vision, cataracts, glaucoma, age related macular degeneration, and diabetic retinopathy.


Read more or order now





Health Topic Pages